comparemela.com

Latest Breaking News On - Quarter for olema pharmaceuticals - Page 1 : comparemela.com

Cyrus Harmon Sells 5,000 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Stock

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) Director Cyrus Harmon sold 5,000 shares of the business’s stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $10.93, for a total value of $54,650.00. Following the completion of the transaction, the director now owns 786,283 shares […]

Cyrus-harmon
Clarivest-asset-management
Silverarc-capital-management
Goldman-sachs-group
Olema-pharmaceuticals
Quarter-for-olema-pharmaceuticals
Victory-capital-management-inc
News-ratings-for-olema-pharmaceuticals-daily
Nasdaq
Vivo-capital
Olema-pharmaceuticals-inc
Institutional-investors-weigh-in-on-olema-pharmaceuticals

Cyrus Harmon Sells 5,000 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Stock

Cyrus Harmon Sells 5,000 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Stock
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

China
Cyrus-harmon
Nasdaq
Olema-pharmaceuticals-company-profile
Olema-pharmaceuticals-inc
Olema-pharmaceuticals-stock
Securities-exchange-commission
Goldman-sachs-group
Quarter-for-olema-pharmaceuticals
Victory-capital-management-inc
Vanguard-group-inc
News-ratings-for-olema-pharmaceuticals-daily

ClariVest Asset Management LLC Buys 12,700 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA)

ClariVest Asset Management LLC raised its stake in shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Free Report) by 23.9% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 65,900 shares of the company’s stock after buying an additional 12,700 shares during the period. ClariVest Asset Management LLC […]

United-states
American
Cyrus-harmon
G-walmsley-graham
American-international-group-inc
Quarter-for-olema-pharmaceuticals
Clarivest-asset-management
Nasdaq
Raymond-james-financial-services-advisors-inc
Olema-pharmaceuticals
Silverarc-capital-management
Olema-pharmaceuticals-inc

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Director Sells $78,200.00 in Stock

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) Director Cyrus Harmon sold 5,000 shares of Olema Pharmaceuticals stock in a transaction that occurred on Thursday, November 2nd. The shares were sold at an average price of $15.64, for a total transaction of $78,200.00. Following the transaction, the director now directly owns 943,714 shares of the […]

Canada
California
United-states
Cyrus-harmon
Nasdaq
Quarter-for-olema-pharmaceuticals
Credit-suisse-group
Olema-pharmaceuticals-inc
Ep-wealth-advisors
Wells-fargo-company
Olema-pharmaceuticals-stock-performance
News-ratings-for-olema-pharmaceuticals-daily

vimarsana © 2020. All Rights Reserved.